Significant Sequential Revenue Growth
Sequential revenue growth of 62% in the second fiscal quarter, driven by a substantial increase in distributor sales of 147% or $101,000.
High Gross Margins Maintained
Maintained high gross margins of 89.5% in the second fiscal quarter.
Expansion of Distribution Network
Surpassed distribution to more than 800 clinics across all 50 states, with the aim to expand to over 1,500 clinics by the end of the fiscal year.
Successful Cost Reduction
Operating expenses decreased by 25% compared to the same quarter of the previous year, due to strategic restructuring.
Improved Net Loss
Net loss improved to $2.2 million or $0.11 loss per share from a net loss of $3.7 million or $0.28 per share in the same quarter a year ago.
Expansion of Sales and Marketing Team
Added highly experienced sales and marketing personnel to support growing distribution relationships and direct sales.